Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxytyrosol for Breast Cancer Prevention
NCT02068092Phase 3Completed
- Sponsor
- Houston Methodist Research Institute
- Start
- Dec 2013
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxytyrosol in breast cancer, sponsored by Houston Methodist Research Institute. Started Dec 2013; status: completed.
02
Drugs
hydroxytyrosol
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02068092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02068092.